Participants should be receiving guideline recommended HF medications as prescribed by their treating physician(s) [such as ACEi, ARB, beta-adrenergic blocking agent or beta blocker (βblocker), oral diuretics, MRA, angiotensin receptor-neurolysin inhibitor]. This evidence concerns the gene NLN and hydrops fetalis.